Literature DB >> 7189252

ALS in Rochester, Minnesota, 1925-1977.

S M Juergens, L T Kurland, H Okazaki, D W Mulder.   

Abstract

The incidence, trend, and survivorship of ALS in the population of Rochester, Minnesota, was determined for the years 1925 through 1977. The average annual incidence was 1.76 per 100,000 population. There was a small but nonsignificant increase in the rate during the 53-year period. The male:female ratio was 1.1, and the male:female ratio of incidence rates was 1.6. The median age at onset was 66 years; the incidence rates increased with increasing age. Median survivorship was 22.5 months, and was longer for younger patients than for patients with an advanced age at onset. The demographic characteristics in this total community experience are believed to reflect the pattern of ALS more accurately than previously reported clinical series.

Entities:  

Mesh:

Year:  1980        PMID: 7189252     DOI: 10.1212/wnl.30.5.463

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 3.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 4.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

5.  Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study.

Authors:  G Salemi; B Fierro; A Arcara; M Cassata; M G Castiglione; G Savettieri
Journal:  Ital J Neurol Sci       Date:  1989-10

6.  Preclinical and subclinical events in motor neuron disease.

Authors:  M Swash; D Ingram
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

7.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

8.  Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases.

Authors:  Brian Lenhart; Xiaojun Wei; Zehui Zhang; Xiaoqin Wang; Qian Wang; Chang Liu
Journal:  Crit Rev Biomed Eng       Date:  2020

9.  Motor neurone disease in the Lothian Region of Scotland 1961-81.

Authors:  S M Holloway; J D Mitchell
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

10.  Cerebral atrophy in motor neuron disease evaluated by computed tomography.

Authors:  M Poloni; C Mascherpa; L Faggi; F Rognone; L Gozzoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.